![](https://investorshub.advfn.com/uicon/434772.png?cb=1479377918)
Wednesday, March 14, 2018 11:08:57 AM
Here is an extract of the article:
Neuroderm Chief Scientist Officer Dr. Oron Yacoby-Zeevi may seem rather unassuming when compared to some of the other game-changers on this list, but there’s a very good reason she joins the other nine candidates. Israel’s Neuroderm, a clinical-stage pharmaceutical firm developing next-generation treatments for disorders of the central nervous system, was sold to Mitsubishi Tanabe Pharma for $1.1 billion in what is said to be Israel’s largest Pharma exit earlier this year. Yacoby-Zeevi, according to a report in Globes, had a hand in that exit, at least in part, because she is responsible for the company’s technological solution. NeuroDerm has developed a liquid version of a drug already in existence to treat Parkinson’s Disease. This groundbreaking achievement will certainly improve the lives of patients around the world who suffer from the disease, while also generating profits for the company
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM